| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $1.78B | $1.97B | $1.46B |
| YoY Revenue Growth % | -9.8% | +35.4% | — |
| Gross Profit | — | — | — |
| Gross Margin % | — | — | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$560.3M | $172.9M | $209.8M |
| Operating Margin % | -31.5% | 8.8% | 14.4% |
| Net Income (GAAP) | -$494.3M | -$76.4M | $187.0M |
| EBITDA (Normalized) | -$496.2M | $244.0M | $262.3M |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $935.8M | $962.6M | $519.1M |
| Capital Expenditures (CapEx) | $80.1M | $88.8M | $65.6M |
| Free Cash Flow (FCF) | $855.7M | $873.8M | $453.5M |
| FCF Margin % | 48.1% | 44.3% | 31.1% |
| Return on Invested Capital (ROIC %) | -14.6% | 3.5% | 15.7% |
| Cash & Short-Term Equivalents | $362.8M | $108.2M | — |
| Total Debt (Short + Long Term) | $1.23B | $1.22B | $409.4M |
| Total Stockholders' Equity | $2.17B | $2.76B | $839.7M |